Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone
- 28 February 1998
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 69 (2), 189-194
- https://doi.org/10.1016/s0015-0282(97)00501-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comprehensive Pharmacokinetics of Urinary Human Follicle Stimulating Hormone in Healthy Female VolunteersPharmaceutical Research, 1995
- Comparing the glycosylation patterns of recombinant glycoproteinsTrends in Biotechnology, 1992
- Standardization of symbols in clinical pharmacologyEuropean Journal of Clinical Pharmacology, 1988
- Clinical—pharmacological studies on human menopausal gonadotrophinHuman Reproduction, 1988
- Structure of Human Luteinizing Hormone Alpha SubunitEndocrine Research Communications, 1978
- Disappearance Rates of Endogenous Luteinizing Hormone and Chorionic Gonadotropin in ManJournal of Clinical Endocrinology & Metabolism, 1968
- EFFECTS OF HUMAN MENOPAUSAL GONADOTROPHIN PREPARATIONS IN DIFFERENT BIOASSAY METHODSActa Endocrinologica, 1964
- ASSAY OF THE FOLLICLE STIMULATING HORMONE BASED ON THE AUGMENTATION WITH HUMAN CHORIONIC GONADOTROPINEndocrinology, 1953